Workflow
康复机器人
icon
Search documents
张江独角兽,完成超6亿元融资 | 融资周报(2025年第34期)
Sou Hu Cai Jing· 2025-09-17 06:11
Financing Overview - A total of 23 financing events occurred in Shanghai this week, with Zhangjiang accounting for 7 and Lingang for 2 [2] - The financing amount disclosed this week reached approximately 1.731 billion yuan, with 6 out of 23 events revealing their amounts [4] - The number of financing events increased by 5 compared to the previous week, which had 18 events [4] Company Dynamics - YaoTang Biotech announced research results on LNP-mRNA mediated in vivo gene editing of hematopoietic stem cells on August 12 [3] - On September 4, RuShen Robotics was selected for Tencent's 2025 Silver Technology Partner Program [3] - HengRui Medicine's subsidiary received approval for its first mRNA gene drug Phase II clinical trial on September 10 [5] - The China-Russia Medical Technology and Equipment Cooperation Center was established in Pudong on September 11 [5] - AstraZeneca's long-acting C5 complement inhibitor was launched in China on September 12 [5] Financing Rounds - The majority of financing events this week were in the angel round, totaling 9, followed by 7 in the A round [6] - B round financing reached a significant amount of 60 million USD [6] Industry Focus - Financing events this week spanned 11 industries, with the healthcare sector leading with 5 events, followed by artificial intelligence with 3 [9] Notable Financing Highlights - Zhenqu Technology completed over 600 million yuan in E round financing on September 8, led by Guotou Innovation and Guotou Investment [13] - Yijielike completed 60 million USD in B round financing on September 8, led by Longpan Investment [15] - New Electric Hero secured nearly 300 million yuan in strategic financing on September 10, exclusively invested by BAI Capital [17] - YaoTang Biotech completed over 300 million yuan in B round financing on September 10, led by AstraZeneca's CICC Medical Industry Fund [19] - RuShen Robotics completed several million yuan in angel+ round financing on September 9, exclusively funded by Daotong Investment [22] Hot Industry Focus - This week saw 5 financing events related to healthcare, including 2 in gene technology: Yijielike's 60 million USD B round and YaoTang Biotech's over 300 million yuan B round [24] - The surge in gene therapy investments is driven by policy support, with Shanghai's Science and Technology Commission announcing a special fund for gene therapy research, with a maximum grant of 5 million yuan per project [24]
AI赋能康复产业 机器人“读懂”患者“想做什么”
Shen Zhen Shang Bao· 2025-08-07 17:00
Core Insights - The 22nd Shenzhen International Rehabilitation Forum focused on "Artificial Intelligence Empowering Rehabilitation," gathering global experts to discuss revolutionary breakthroughs in rehabilitation healthcare through AI technology [1] Group 1: AI in Rehabilitation - The forum included a significant component on the application of AI in rehabilitation medicine, featuring discussions led by prominent experts, including Academician Li Jian'an, who emphasized the core principles, technical support, application scenarios, and development prospects of AI in rehabilitation [2] - Big data is identified as the core foundation of AI, with its value depending not only on the volume of data but also on its continuity, systematization, and precision [2] - The integration of human body sensors for high-quality health data acquisition and AI for data analysis is expected to drive profound changes in medical thinking and treatment methods [2] Group 2: Technological Innovations - Shenzhen is recognized as one of the first 12 national comprehensive innovation pilot areas for rehabilitation assistive devices, fostering numerous high-tech companies focused on intelligent rehabilitation [3] - Shenzhen Jianlitong Intelligent Robot Co., Ltd., the forum's organizer, specializes in the research, production, and sales of rehabilitation robots and related high-tech products, highlighting AI's role in reshaping the rehabilitation healthcare system [3] - The use of multimodal data fusion technology in lower limb exoskeleton rehabilitation training systems allows for early rehabilitation training for patients with motor function impairments, effectively activating neural pathways [3] - This technology enables rehabilitation robots to accurately interpret patient intentions, transitioning from passive execution to active guidance, akin to equipping robots with a "multisensory system" [3]
2025Q1小巨人企业融资事件同比减少超两倍,IPO数量环比增加近三成丨2025Q1专精特新小巨人企业资本市场发展报告
创业邦· 2025-05-31 03:29
Core Insights - The number of specialized and innovative "little giant" enterprises in China exceeds 14,000, with Jiangsu, Guangdong, and Zhejiang leading in quantity [3][5][25] - Financing events and amounts for these enterprises have significantly decreased, with a 55% drop in events and a 48.1% decline in disclosed financing amounts in Q1 2025 compared to the previous year [9][12] - The number of IPOs for these enterprises has increased, with 19 IPOs in Q1 2025, marking a 26.7% year-on-year growth [24][25] Group 1: Development Overview - As of March 31, 2025, there are 14,687 specialized and innovative "little giant" enterprises in China, with Jiangsu having 2,160, Guangdong 1,985, and Zhejiang 1,804 [5][25] - The top five cities with the highest number of these enterprises are Beijing, Shenzhen, Shanghai, Suzhou, and Hangzhou [5] Group 2: Financing Overview - In Q1 2025, there were 136 financing events for specialized and innovative "little giant" enterprises, a decrease of 55% year-on-year, with disclosed financing amounting to 9.85 billion RMB, down 48.1% [9][12] - Jiangsu, Beijing, Guangdong, Shanghai, and Zhejiang are the leading regions in financing activity, with Shanghai having the highest financing amount exceeding 9 billion RMB [12] Group 3: IPO Insights - The number of IPOs for specialized and innovative "little giant" enterprises in Q1 2025 was 19, reflecting a 26.7% increase year-on-year [24] - Among the 27 new IPOs in A-shares, 18 were specialized and innovative "little giant" enterprises, accounting for 66.7% [25] Group 4: M&A Activity - In Q1 2025, there were 29 disclosed M&A events involving specialized and innovative "little giant" enterprises, a significant increase of 262.5% year-on-year, with a total disclosed transaction amount of 5.16 billion RMB, up 26.8% [34] Group 5: Recent Developments - In March 2025, the Ministry of Industry and Information Technology and 15 other departments issued guidelines to enhance compliance awareness and management among small and medium-sized enterprises, including specialized and innovative "little giant" enterprises [39]
南京发布百余场全国助残日活动 科技助残“柔性手部康复机器人”惊艳亮相
Yang Zi Wan Bao Wang· 2025-05-14 12:09
Group 1 - The core theme of the event is to promote the spirit of self-reliance and assistance for the disabled, with over 100 diverse activities planned in Nanjing to support this cause [2][3] - The event includes various activities such as swimming and curling competitions for disabled individuals, product exhibitions, talent shows for disabled children, and specialized job fairs [2][3] - The activities aim to enhance public understanding of disability assistance policies and share success stories of disabled individuals overcoming challenges [3] Group 2 - The Southeast University team showcased an innovative flexible hand rehabilitation robot, which is designed to assist patients with hand rehabilitation, a challenging area due to the complexity of hand structures [4] - The robot utilizes fabric materials and provides over 20N of gripping force, enabling bidirectional movement of fingers, which is a significant improvement over existing flexible actuators [4] - Clinical trials involving over 100 patients at Jiangsu Provincial People's Hospital and Southeast University Affiliated Zhongda Hospital have shown significant improvements in rehabilitation outcomes, highlighting the potential of technology in disability assistance [4]